(L to R) Lifeyear co-founders Siim Saare, Dr Eleanor Wicks and Timo Mitt (Credit: Lifeyear)
UK-Estonian health technology start-up Lifeyear has raised €2.8 million (£2.4m) to launch its remote patient management platform for cardiovascular…
Continue Reading
What You Should Know:
– Sleep Cycle, a sleep technology company, announced the commencement of a clinical study to validate its forthcoming smartphone-based feature for screening and monitoring obstructive sleep apnea (OSA).
– The feature will…
Continue Reading
Researchers at Imperial College London have developed a generative AI model that creates realistic and personalised animations of human hearts to help identify abnormalities.
The Imperial team used images of real human hearts from more…
Digital screening may divert lower-risk persons to lower-cost online screening, or offer higher-risk non-responders a more acceptable alternative. Population-based uptake estimates are lacking. We conducted four studies within four weeks by inviting 1700 Londoners…
Continue Reading
R. Kirk Huntsman, Chairman and CEO, Co-Founder at Vivos Therapeutics
Sleep is essential, yet millions worldwide unknowingly suffer from sleep disorders, especially Obstructive Sleep Apnea (OSA), which contributes to up to 40 severe health complications…
Continue Reading
AI-driven heart scans which cut the need for invasive tests have saved millions of pounds, according to an analysis.
The Heartflow technology, which has been rolled out across 56 hospitals in England since 2021,…
Despite significant advances, the prevention and management of cardiovascular disease remain challenging, especially for ischemic heart disease (IHD). Current clinical decision-making relies heavily on physician expertise, guideline-directed therapies, and static risk scores, which often…
Continue Reading
Metabolic syndrome is leading to an increased risk of diabetes and cardiovascular disease. Our study developed a model using retinal image data from fundus photographs taken during comprehensive health check-ups to classify metabolic syndrome….
Continue Reading
Stuart Long, CEO, InfoBionic.Ai
Cardiovascular disease (CVD) is a leading cause of death and a growing financial strain on the U.S. healthcare system, costing an estimated $252.2 billion annually. With one in every eight healthcare…
Continue Reading
Source: GE Healthcare
What You Should Know:
– GE HealthCare launches of its Revolution Vibe CTi, a new computed tomography (CT) system designed to elevate patient care by providing advanced cardiac imaging technology.
– The system aims…
Continue Reading
